Extendicare (TSE:EXE – Free Report) had its price objective cut by Desjardins from C$40.00 to C$39.00 in a research note released on Monday,BayStreet.CA reports. They currently have a buy rating on the stock.
EXE has been the subject of a number of other research reports. BMO Capital Markets boosted their price target on Extendicare from C$30.00 to C$38.00 in a research note on Wednesday, May 13th. Canaccord Genuity Group upgraded shares of Extendicare to a “strong-buy” rating in a research note on Monday, May 11th. National Bank Financial raised their target price on shares of Extendicare from C$34.00 to C$40.00 and gave the company an “outperform” rating in a report on Wednesday, May 27th. Finally, TD raised their target price on shares of Extendicare from C$32.00 to C$39.00 and gave the company a “buy” rating in a report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. Based on data from MarketBeat.com, Extendicare currently has a consensus rating of “Buy” and a consensus target price of C$35.44.
Get Our Latest Stock Report on Extendicare
Extendicare Trading Up 1.2%
Extendicare (TSE:EXE – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported C$0.32 earnings per share for the quarter. The firm had revenue of C$611.04 million during the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%. On average, research analysts anticipate that Extendicare will post 0.6134729 EPS for the current fiscal year.
Extendicare Announces Dividend
The firm also recently announced a monthly dividend, which will be paid on Monday, August 17th. Shareholders of record on Monday, August 17th will be issued a $0.0441 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, July 31st. Extendicare’s dividend payout ratio (DPR) is currently 39.23%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
